Notes to SEFA
The Schedule of Expenditures of Federal Awards presents the activity of all federal award programs of Biomedical Research and Innovation Park, Inc. The reporting entity is defined in Note 1 to Biomedical Research and Innovation Park, Inc.’s financial statements. All federal award programs received directly from federal agencies, as well as federal awards passed through other government agencies, are included on the schedule.
The Schedule of Expenditures of Federal Awards is presented using the accrual basis of accounting, which is described in Note 1 to Biomedical Research and Innovation Park, Inc.’s financial statements. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.
Biomedical Research and Innovation Park, Inc. did not elect to use the 10% de minimis federal indirect cost rate for the year ended December 31, 2024.